Bicyclohexyl
new

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 591724

CAS#: 92-51-3

Description: Bicyclohexyl is a component of important biochemicals.


Price and Availability

Size
Price

5g
USD 210
Size
Price

100g
USD 590
Size
Price

Bicyclohexyl; purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 591724
Name: Bicyclohexyl
CAS#: 92-51-3
Chemical Formula: C12H22
Exact Mass: 166.1722
Molecular Weight: 166.31
Elemental Analysis: C, 86.67; H, 13.33


Synonym: Bicyclohexyl; AI3-01174; AI3 01174; AI301174

IUPAC/Chemical Name: 1,1'-Bicyclohexyl

InChi Key: WVIIMZNLDWSIRH-UHFFFAOYSA-N

InChi Code: InChI=1S/C12H22/c1-3-7-11(8-4-1)12-9-5-2-6-10-12/h11-12H,1-10H2

SMILES Code: C1(C2CCCCC2)CCCCC1


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>3 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
2934.99.03.00


References

1: Sai DV, Kumar TA, Haase W, Roy A, Dhara S. Effect of smectic short-range order on the discontinuous anchoring transition in nematic liquid crystals. J Chem Phys. 2014 Jul 28;141(4):044706. doi: 10.1063/1.4890532. PubMed PMID: 25084936.

2: Uehara M, Aya S, Araoka F, Ishikawa K, Takezoe H, Morikawa J. Discontinuous thermal diffusivity change due to the anchoring transition of a liquid crystal on a perfluoropolymer surface. Chemphyschem. 2014 May 19;15(7):1452-6. doi: 10.1002/cphc.201300975. Epub 2014 Feb 13. PubMed PMID: 24677707.

3: Barret LA, Barrot-Ivolot C, Raynal S, Jungas C, Polidori A, Bonneté F. Influence of hydrophobic micelle structure on crystallization of the photosynthetic RC-LH1-PufX complex from Rhodobacter blasticus. J Phys Chem B. 2013 Jul 25;117(29):8770-81. doi: 10.1021/jp403483q. Epub 2013 Jul 10. PubMed PMID: 23806126.

4: de Groen M, Vlugt TJ, de Loos TW. Phase behavior of liquid crystals with CO2. J Phys Chem B. 2012 Aug 2;116(30):9101-6. doi: 10.1021/jp303426k. Epub 2012 Jul 11. PubMed PMID: 22731661.

5: Loginova KA, Knyazev VD. Kinetics of the self reaction of cyclohexyl radicals. J Phys Chem A. 2011 Aug 11;115(31):8616-22. doi: 10.1021/jp204012w. Epub 2011 Jul 20. PubMed PMID: 21702489.

6: Liao W, Pan HB, Liu HW, Chen HJ, Wai CM. Kinetic study of hydrodechlorination of chlorobiphenyl with polymer-stabilized palladium nanoparticles in supercritical carbon dioxide. J Phys Chem A. 2009 Sep 10;113(36):9772-8. doi: 10.1021/jp9008459. PubMed PMID: 19685923.

7: Betz R, Klüfers P. From simple diols to carbohydrate derivatives of phenylarsonic acid. Inorg Chem. 2009 Feb 2;48(3):925-35. doi: 10.1021/ic8014018. PubMed PMID: 19166366.

8: Deschamps J, Trusler JP, Jackson G. Vapor pressure and density of thermotropic liquid crystals: MBBA, 5CB, and novel fluorinated mesogens. J Phys Chem B. 2008 Apr 3;112(13):3918-26. doi: 10.1021/jp711211w. Epub 2008 Mar 11. PubMed PMID: 18331024.

9: McBriar MD, Guzik H, Shapiro S, Xu R, Paruchova J, Clader JW, O'neill K, Hawes B, Sorota S, Margulis M, Tucker K, Weston DJ, Cox K. Bicyclo[3.1.0]hexyl urea melanin concentrating hormone (MCH) receptor-1 antagonists: impacting hERG liability via aryl modifications. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4262-5. Epub 2006 Jun 5. PubMed PMID: 16753297.

10: Yoshikawa K, Suzuki K, Umeyama A, Arihara S. Abietane diterpenoids from the barks of Cryptomeria japonica. Chem Pharm Bull (Tokyo). 2006 Apr;54(4):574-8. PubMed PMID: 16595970.

11: Nomura Y, Nakai S, Hosomi M. Elucidation of degradation mechanism of dioxins during mechanochemical treatment. Environ Sci Technol. 2005 May 15;39(10):3799-804. PubMed PMID: 15952388.

12: Hoogesteger FJ, van Walree CA, Jenneskens LW, Roest MR, Verhoeven JW, Schuddeboom W, Piet JJ, Warman JM. Photoinduced intramolecular charge separation in donor/acceptor-substituted bicyclohexylidene and bicyclohexyl. Chemistry. 2000 Aug 18;6(16):2948-59. PubMed PMID: 10993256.

13: Barbier P, Renzetti AR, Turbanti L, Di Bugno C, Fornai F, Vaglini F, Maggio R, Corsini GU. Stereoselective inhibition of muscarinic receptor subtypes by the eight stereoisomers related to rociverine. Eur J Pharmacol. 1995 Jul 18;290(2):125-32. PubMed PMID: 8575526.

14: Ozkutlu U, Long JP, Cannon JG, Sahin MF, Liang C. Prevention of organophosphate-induced toxicity in mice. Arch Int Pharmacodyn Ther. 1995 Mar-Apr;329(2):331-42. PubMed PMID: 8540771.

15: Menicagli S, Lippi A, Criscuoli M, Gervasi PG. Effect of rociverine on P450-dependent monooxygenases and its N-deethylation metabolism in rat liver microsomes. Biochem Pharmacol. 1993 Mar 9;45(5):1097-105. PubMed PMID: 8461039.

16: Bhattacharyya B, Sokoll MD, Cannon JG, Long JP. Pharmacologic evaluation and structure activity relationships of a series of hemicholinium-3 (HC-3) analogs. Arch Int Pharmacodyn Ther. 1987 Jul;288(1):136-46. PubMed PMID: 2821940.

17: Bhattacharyya B, Flynn JR, Cannon JG, Long JP. Anticholinesterase activity and structure activity relationships of a new series of hemicholinium-3 analogs. Eur J Pharmacol. 1986 Dec 16;132(2-3):107-14. PubMed PMID: 3028835.

18: D'Agostino G, Zonta F, Santagostino Barbone MG, Grana E, Brunori P, Subissi A. Mechanism of smooth muscle relaxation by rociverine. Arzneimittelforschung. 1984;34(5):584-9. PubMed PMID: 6540576.

19: Krut'ko BT. [Catecholamine regulation of the liver and kidney ATPase activity in mice]. Probl Endokrinol (Mosk). 1982 Jan-Feb;28(1):73-8. Russian. PubMed PMID: 6278463.

20: Schiantarelli P, Murmann W, Magi S. Investigation of rociverine + dipyrone for antispasmodic and analgesic interactions. Arzneimittelforschung. 1979;29(5):760-5. PubMed PMID: 582975.